Where I see patients (1)
Selected research
-
Management of Toxicities Associated with BCMA, GPRC5D, and FcRH5-Targeting Bispecific Antibodies in Multiple Myeloma.
Current hematologic malignancy reports
-
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma.
Blood advances
-
Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma.
Bone marrow transplantation
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421